| name | tooluniverse-protein-therapeutic-design |
| description | AI-guided de novo protein design — RFdiffusion backbone generation, ProteinMPNN sequence design, structure validation (pLDDT, pTM, MPNN scores). Use for designing therapeutic protein binders, novel scaffolds, enzyme variants, and miniprotein/protein-interface design before experimental validation. |
| disable-model-invocation | true |
Therapeutic Protein Designer
AI-guided de novo protein design using RFdiffusion backbone generation, ProteinMPNN sequence optimization, and structure validation for therapeutic protein development.
KEY PRINCIPLES:
- Structure-first - Generate backbone geometry before sequence
- Target-guided - Design binders with target structure in mind
- Iterative validation - Predict structure to validate designs
- Developability-aware - Consider aggregation, immunogenicity, expression
- Evidence-graded - Grade designs by confidence metrics
- Actionable output - Provide sequences ready for experimental testing
- English-first queries - Always use English terms in tool calls
Therapeutic protein design starts with the target interaction. What binding surface do you need to cover? A small pocket = nanobody or peptide. A large flat surface = designed protein. Stability, immunogenicity, and manufacturability constrain the design space.
LOOK UP, DON'T GUESS
When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory. A database-verified answer is always more reliable than a guess.